14TM Ltd Announces A Collaborative Venture With NIDA To Design And Assay New Therapeutics For Treatment Of Drug Abuse

October 19, 2005 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

14TM Ltd., a GPCR structure and function company, today announce their participation in a collaborative venture with the National Institute on Drug Abuse (NIDA) in design, synthesis and assay of agents for treatment of drug abuse and dependency.

Twitter
LinkedIn
Facebook
Email
Print

Alliances